Correct Capital Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
1,754
-149
-8% -$151K 0.3% 44
2025
Q4
$2.05M Buy
1,903
+48
+3% +$45.9K 0.38% 39
2025
Q3
$1.42M Buy
1,855
+367
+25% +$273K 0.23% 53
2025
Q2
$1.16M Buy
1,488
+1,009
+211% +$784K 0.17% 54
2025
Q1
$395K Buy
479
+30
+7% +$25K 0.06% 90
2024
Q4
$346K Buy
449
+29
+7% +$24K 0.07% 90
2024
Q3
$372K Sell
420
-79
-16% -$71K 0.08% 95
2024
Q2
$452K Hold
499
0.11% 81
2024
Q1
$388K Hold
499
0.09% 96
2023
Q4
$291K Buy
+499
New +$291K 0.07% 101

Other funds holding LLY

Correct Capital Wealth Management's LLY Position: Q1 2026 in Review

Correct Capital Wealth Management reduced its Eli Lilly (LLY) stake by 7.8% in Q1 2026, selling an estimated $151K and leaving 1,754 shares worth $1.61M. The position accounts for 0.3% of the portfolio, ranked #44.

Correct Capital Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.05M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Correct Capital Wealth Management held 1,754 shares of Eli Lilly worth $1.61M as of Q1 2026.
  • Correct Capital Wealth Management sold 149 Eli Lilly shares in Q1 2026, an estimated $151K.
  • Eli Lilly made up 0.3% of Correct Capital Wealth Management's portfolio in Q1 2026, its #44 holding.
  • Correct Capital Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Correct Capital Wealth Management's Eli Lilly position peaked at $2.05M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Correct Capital Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.